Using paraffin immunohistochemistry, TRPV1 and TRPA1 protein expression was found in 62% of the WHO grade II astrocytomas, 37.5% of the anaplastic astrocytomas (WHO grade III), and 16.3% of GBM cases [234]. This evidence concerns the gene TRPA1 and astrocytoma (excluding glioblastoma).